FGFR1 gene fusions in a subset of pediatric mesenchymal tumors: Expanding the genetic spectrum of tumors sharing histologic overlap with infantile fibrosarcoma and "NTRK-rearranged" spindle cell neoplasms. Read more about FGFR1 gene fusions in a subset of pediatric mesenchymal tumors: Expanding the genetic spectrum of tumors sharing histologic overlap with infantile fibrosarcoma and "NTRK-rearranged" spindle cell neoplasms.
Hereditary leiomyomatosis and renal cell carcinoma syndrome associated uterine smooth muscle tumors: Bridging morphology and clinical screening. Read more about Hereditary leiomyomatosis and renal cell carcinoma syndrome associated uterine smooth muscle tumors: Bridging morphology and clinical screening.
Patterns of chromosome 18 loss of heterozygosity in multifocal ileal neuroendocrine tumors. Read more about Patterns of chromosome 18 loss of heterozygosity in multifocal ileal neuroendocrine tumors.
Predisposing germline mutations in high hyperdiploid acute lymphoblastic leukemia in children. Read more about Predisposing germline mutations in high hyperdiploid acute lymphoblastic leukemia in children.
TMEM16A/ANO1 suppression improves response to antibody-mediated targeted therapy of EGFR and HER2/ERBB2. Read more about TMEM16A/ANO1 suppression improves response to antibody-mediated targeted therapy of EGFR and HER2/ERBB2.
Integrated analysis of genome-wide copy number alterations and gene expression in microsatellite stable, CpG island methylator phenotype-negative colon cancer. Read more about Integrated analysis of genome-wide copy number alterations and gene expression in microsatellite stable, CpG island methylator phenotype-negative colon cancer.
Identification of a novel, recurrent HEY1-NCOA2 fusion in mesenchymal chondrosarcoma based on a genome-wide screen of exon-level expression data. Read more about Identification of a novel, recurrent HEY1-NCOA2 fusion in mesenchymal chondrosarcoma based on a genome-wide screen of exon-level expression data.
Copy number alterations in prostate tumors and disease aggressiveness. Read more about Copy number alterations in prostate tumors and disease aggressiveness.
Molecular profiling reveals frequent gain of MYCN and anaplasia-specific loss of 4q and 14q in Wilms tumor. Read more about Molecular profiling reveals frequent gain of MYCN and anaplasia-specific loss of 4q and 14q in Wilms tumor.
Chromosomal copy number alterations are associated with tumor response to chemoradiation in locally advanced rectal cancer. Read more about Chromosomal copy number alterations are associated with tumor response to chemoradiation in locally advanced rectal cancer.
